e-learning
resources
Glasgow 2004
Monday 06.09.2004
Heart and lung
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The incidence and significance of elevated B-type natriuretic peptide levels in patients hospitalized with apparent respiratory diseases
G. Chua, A. P. Chua, S. Sethi, T. K. Lim (Nuh, Singapore)
Source:
Annual Congress 2004 - Heart and lung
Session:
Heart and lung
Session type:
Thematic Poster Session
Number:
1814
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Chua, A. P. Chua, S. Sethi, T. K. Lim (Nuh, Singapore). The incidence and significance of elevated B-type natriuretic peptide levels in patients hospitalized with apparent respiratory diseases. Eur Respir J 2004; 24: Suppl. 48, 1814
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia
Diagnosis and treatment of chronic pulmonary embolism
Related content which might interest you:
Diagnostic value of N-terminal pro-brain natriuretic peptide in patients with COPD with chronic hypoxemic respiratory failure.
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020
Serum levels of high sensitivity cardiac troponin and B-type natriuretic peptide in patients with COPD-OSA overlap syndrome
Source: Sleep and Breathing Conference 2021
Year: 2021
B-type natriuretic peptide (BNP) in COPD patients with acute respiratory failure (ARF)
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
The use of plasma n-terminal pro B-type natriuretic peptide (proBNP) concentrations in differential diagnosis of comorbidity pulmonary patients
Source: Annual Congress 2011 - Acute respiratory failure
Year: 2011
Brain natriuretic peptide (BNP) determination in patients hospitalized for COPD exacerbation
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
The utility of brain natriuretic peptide in patients with stable chronic lung diseases
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012
Brain natriuretic peptide (BNP) levels during acute exacerbations of COPD – a novel biomarker
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
Pro-adrenomedullin, pro-atrial natriuretic peptide and procalcitonin levels at admission in patients with community-acquired pneumonia and its correlation with risk scores
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia
Source: Eur Respir J 2007; 30: Suppl. 51, 481s
Year: 2007
The role of N-terminal pro B-type natriuretic peptide in predicting mortality of community acquired pneumonia
Source: International Congress 2019 – Pneumonia in 2019: antimicrobial resistance, cardiovascular complications and diagnosis
Year: 2019
Levels of procalcitonin, neopterin, C-reactive protein and pro-atrial natriuretic peptide in patients with community-acquired pneumonia and its kinetic according to the severity and the development of complications
Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections
Year: 2010
The effect of diuretics on plasma brain natriuretic peptide level in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007
N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patient with acute exacerbations (AE) of COPD
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
Association between obstructive sleep apnea and elevated levels of B-type natriuretic peptide in a community based sample of women
Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Year: 2012
Determination of B-type natriuretic peptide in patients with chronic heart failure and Cheyne-Stokes respiration
Source: Eur Respir J 2004; 24: Suppl. 48, 563s
Year: 2004
Prognostic value of serum N-terminal brain natriuretic peptide type B for pulmonary hypertension among patients with usual interstitial pneumonia and sarcoidosis
Source: Annual Congress 2007 - Pulmonary vascular involvement in smoking and respiratory diseases
Year: 2007
Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004
The prognostic value of repeated measurements of N-terminal pro-B-type natriuretic peptide in patients with pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010
Presence of inspiratory crackles (IC) in stable chronic obstructive pulmonary disease (COPD) patients; correlation with plasma N-terminal pro-brain natriuretic peptide (NT-BNP) levels
Source: Annual Congress 2008 - Assessment of the respiratory system
Year: 2008
Elevated brain natriuretic peptide predicts mortality in interstitial lung disease
Source: Eur Respir J 2010; 36: 819-825
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept